Phase I and II trials of novel anti-cancer agents: Endpoints, efficacy and existentialism - The Michel Clavel lecture, held at the 10th NCI-EORTC Conference on New Drugs in Cancer Therapy, Amsterdam, 16-19 June 1998

被引：75

作者：

Eisenhauer, EA ^{[1
]}

机构：

[1] Queens Univ, NCIC Clin Trials Grp, Invest New Drug Program, Kingston, ON K7L 3N6, Canada

来源：

ANNALS OF ONCOLOGY | 1998年 / 9卷 / 10期

关键词：

phase I; phase II; response; toxicity;

D O I：

10.1023/A:1008497110734

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1047 / 1052

页数：6

共 9 条

[1]

DENT S, 1996, ANN ONCOL S1, V7, P134

[2] ONE-SAMPLE MULTIPLE TESTING PROCEDURE FOR PHASE-II CLINICAL-TRIALS [J].

FLEMING, TR .

BIOMETRICS, 1982, 38 (01) :143-151

[3] DRUG-DELIVERY ANALYSIS OF THE CANADIAN MULTICENTER TRIAL IN NON-SMALL-CELL LUNG-CANCER [J].

MURRAY, N ;

COPPIN, C ;

COLDMAN, A ;

PATER, J ;

RAPP, E .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) :2333-2339

[4] CHEMOTHERAPY CAN PROLONG SURVIVAL IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER - REPORT OF A CANADIAN MULTICENTER RANDOMIZED TRIAL [J].

RAPP, E ;

PATER, JL ;

WILLAN, A ;

CORMIER, Y ;

MURRAY, N ;

EVANS, WK ;

HODSON, DI ;

CLARK, DA ;

FELD, R ;

ARNOLD, AM ;

AYOUB, JI ;

WILSON, KS ;

LATREILLE, J ;

WIERZBICKI, RF ;

HILL, DP .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (04) :633-641

[5]

RASMUSSEN H, 1997, P AN M AM SOC CLIN, V16, pA429

[6]

RUSTIN GJS, 1997, P AM SOC CLIN ONCOL, V16, pA351

[7] Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer [J].

Thalmann, GN ;

Sikes, RA ;

Chang, SM ;

Johnston, DA ;

vonEschenbach, AC ;

Chung, LWK .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (12) :794-801

[8] PET scanning in clinical oncology [J].

Timothy, AR ;

Cook, GJR .

ANNALS OF ONCOLOGY, 1998, 9 (04) :353-355

[9]

ZEE B, 1996, CONTROLLED CLIN TRIA, V17, pS85

← 1 →